Brain+ has signed its first sales contract on CST-Therapist Companion with the municipality of Syddjurs. In addition, the sales contract signed with the municipality of Herning in First Quarter 2023 has been extended, representing the first repeat sale of the product. Including the important reference sales contract closed with the Copenhagen municipality in December 2023, the company has closed three (3) additional Danish CST-Therapist Companion contracts around the turn of the year in line with announced expectations.

Brain+ released the first Danish version of CST-Therapist Companion in late 2022 as a digital solution to support care personnel in the municipalities deliver Cognitive Stimulation Therapy (CST) to people with mild to moderate dementia. CST is an evidence based non-pharmaceutical therapy, delivered over 14 sessions to groups of typically 4-8 people with dementia, and which has been shown to delay cognitive decline and improve both social skills and quality of life. CST is recommended by the World Alzheimer's Association and gaining increased recognition worldwide, but implementation barriers exist.

Specifically, the implementation of procedures to deliver CST, and the need for preparation of material to the group sessions. In addition, the benefits of the therapy depend on the consistent delivery of high-quality content in accordance with the CST method. CST-Therapist Companion addresses these main barriers for adoption, specifically by reducing preparation time for therapists to allow more face-to-face time with patients, offering consistent CST delivery according to the method, altogether allowing an easier and less resource intensive implementation.

The quality assurance of the product instills trust in therapists as the content and methods are developed closely and with strict approval procedures with leading CST experts from the CST inventor Amiee Spector's group at University College of London (UCL). The five sales contracts on CST, Brain+ has signed so far with Danish municipalities on CST-Therapist Companion cover access to use the product in a select number of dementia care centers, where CST is currently offered. The contracts are considered `foot-in-the-door' sales as a key starting point for Brain+ to establish reference customers and they have a combined value of DKK 0.25 million.

In 2024, Brain+ expects to close new sales contracts with more municipalities and based on the current CST adoption and penetration of digital health products in Denmark, the total 1-2 years' sales potential for CST-Therapist Companion in this market is estimated to be DKK 5-6 million.